Bank of Montreal’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.75M | Buy |
65,500
+1,747
| +3% | +$95.7K | ﹤0.01% | 1478 |
|
|
2026
Q1 | $3.6M | Sell |
63,753
-4,825
| -7% | -$281K | ﹤0.01% | 1439 |
|
|
2025
Q4 | $4.08M | Sell |
68,578
-10,449
| -13% | -$569K | ﹤0.01% | 1403 |
|
|
2025
Q3 | $4.28M | Buy |
79,027
+5,207
| +7% | +$298K | ﹤0.01% | 1361 |
|
|
2025
Q2 | $4.06M | Buy |
73,820
+2,271
| +3% | +$134K | ﹤0.01% | 1334 |
|
|
2025
Q1 | $5.06M | Buy |
71,549
+3,397
| +5% | +$229K | ﹤0.01% | 1165 |
|
|
2024
Q4 | $4.48M | Sell |
68,152
-14,519
| -18% | -$973K | ﹤0.01% | 1254 |
|
|
2024
Q3 | $5.83M | Sell |
82,671
-168,254
| -67% | -$14.1M | ﹤0.01% | 1250 |
|
|
2024
Q2 | $21.4M | Buy |
250,925
+181,935
| +264% | +$15.1M | 0.01% | 743 |
|
|
2024
Q1 | $6.03M | Buy |
68,990
+559
| +0.8% | +$50K | ﹤0.01% | 1147 |
|
|
2023
Q4 | $6.7M | Sell |
68,431
-224,356
| -77% | -$19.8M | ﹤0.01% | 1166 |
|
|
2023
Q3 | $26.5M | Buy |
292,787
+220,464
| +305% | +$19.6M | 0.01% | 622 |
|
|
2023
Q2 | $6.99M | Sell |
72,323
-43,507
| -38% | -$4.09M | ﹤0.01% | 1178 |
|
|
2023
Q1 | $11.3M | Buy |
115,830
+556
| +0.5% | +$57.6K | ﹤0.01% | 895 |
|
|
2022
Q4 | $12.1M | Buy |
115,274
+38,582
| +50% | +$3.62M | 0.01% | 899 |
|
|
2022
Q3 | $6.6K | Sell |
76,692
-181,686
| -70% | -$16.2M | ﹤0.01% | 1202 |
|
|
2022
Q2 | $22.1K | Buy |
258,378
+27,454
| +12% | +$2.19M | 0.01% | 720 |
|
|
2022
Q1 | $18.3M | Buy |
230,924
+75,322
| +48% | +$6.3M | 0.01% | 862 |
|
|
2021
Q4 | $13.9M | Buy |
155,602
+11,755
| +8% | +$970K | 0.01% | 859 |
|
|
2021
Q3 | $11.1M | Buy |
143,847
+9,632
| +7% | +$760K | 0.01% | 1229 |
|
|
2021
Q2 | $11.2M | Sell |
134,215
-2,939
| -2% | -$233K | 0.01% | 1204 |
|
|
2021
Q1 | $10.7M | Buy |
137,154
+36,883
| +37% | +$3.01M | 0.01% | 975 |
|
|
2020
Q4 | $8.15M | Sell |
100,271
-10,029
| -9% | -$795K | 0.01% | 1131 |
|
|
2020
Q3 | $8.33M | Buy |
110,300
+14,683
| +15% | +$1.49M | 0.01% | 935 |
|
|
2020
Q2 | $12.1M | Buy |
95,617
+15,004
| +19% | +$1.49M | 0.01% | 755 |
|
|
2020
Q1 | $6.94M | Sell |
80,613
-14,817
| -16% | -$1.28M | 0.01% | 848 |
|
|
2019
Q4 | $8.07M | Sell |
95,430
-43,978
| -32% | -$3.32M | 0.01% | 1100 |
|
|
2019
Q3 | $9.4M | Buy |
139,408
+54,828
| +65% | +$4.22M | 0.01% | 897 |
|
|
2019
Q2 | $7.25M | Sell |
84,580
-20,434
| -19% | -$1.75M | 0.01% | 1040 |
|
|
2019
Q1 | $9.33M | Sell |
105,014
-4,343
| -4% | -$403K | 0.01% | 882 |
|
|
2018
Q4 | $9.31M | Sell |
109,357
-710
| -0.6% | -$67.5K | 0.01% | 808 |
|
|
2018
Q3 | $10.7M | Sell |
110,067
-4,686
| -4% | -$468K | 0.01% | 873 |
|
|
2018
Q2 | $10.8M | Buy |
114,753
+1,150
| +1% | +$101K | 0.01% | 859 |
|
|
2018
Q1 | $9.21M | Buy |
113,603
+4,469
| +4% | +$384K | 0.01% | 886 |
|
|
2017
Q4 | $9.73M | Buy |
109,134
+6,802
| +7% | +$591K | 0.01% | 866 |
|
|
2017
Q3 | $9.52M | Buy |
102,332
+7,749
| +8% | +$685K | 0.01% | 875 |
|
|
2017
Q2 | $8.59M | Sell |
94,583
-49,330
| -34% | -$4.49M | 0.01% | 911 |
|
|
2017
Q1 | $12.6M | Buy |
143,913
+56,388
| +64% | +$5.02M | 0.01% | 724 |
|
|
2016
Q4 | $7.49M | Sell |
87,525
-2,778
| -3% | -$239K | 0.01% | 910 |
|
|
2016
Q3 | $8.36M | Sell |
90,303
-3,987
| -4% | -$375K | 0.01% | 897 |
|
|
2016
Q2 | $7.34M | Sell |
94,290
-196
| -0.2% | -$16.7K | 0.01% | 946 |
|
|
2016
Q1 | $7.79M | Buy |
94,486
+13,396
| +17% | +$1.09M | 0.01% | 838 |
|
|
2015
Q4 | $8.49M | Buy |
81,090
+7,448
| +10% | +$778K | 0.01% | 788 |
|
|
2015
Q3 | $7.76M | Sell |
73,642
-166,069
| -69% | -$22.2M | 0.01% | 812 |
|
|
2015
Q2 | $32.8M | Buy |
239,711
+197,858
| +473% | +$24.5M | 0.04% | 378 |
|
|
2015
Q1 | $5.22M | Sell |
41,853
-4,175
| -9% | -$442K | 0.01% | 1030 |
|
|
2014
Q4 | $4.16M | Buy |
46,028
+1,397
| +3% | +$116K | ﹤0.01% | 1098 |
|
|
2014
Q3 | $3.22M | Buy |
44,631
+13,356
| +43% | +$878K | ﹤0.01% | 1261 |
|
|
2014
Q2 | $1.95M | Buy |
31,275
+3,951
| +14% | +$239K | ﹤0.01% | 1464 |
|
|
2014
Q1 | $1.86M | Buy |
27,324
+1,948
| +8% | +$144K | ﹤0.01% | 1363 |
|
|
2013
Q4 | $1.78M | Buy |
25,376
+471
| +2% | +$32K | ﹤0.01% | 1229 |
|
|
2013
Q3 | $1.8M | Sell |
24,905
-804
| -3% | -$53.4K | ﹤0.01% | 1207 |
|
|
2013
Q2 | $1.43M | Buy |
+25,709
| New | +$1.6M | ﹤0.01% | 1238 |
|
Other funds holding BMRN
Bank of Montreal's BMRN Position: Q2 2026 in Review
Bank of Montreal increased its BioMarin Pharmaceuticals (BMRN) stake by 2.7% in Q2 2026, buying an estimated $95.7K and bringing the position to 65,500 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1478.
Bank of Montreal first reported a position in BMRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $32.8M in Q2 2015. 526 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Bank of Montreal held 65,500 shares of BioMarin Pharmaceuticals worth $3.75M as of Q2 2026.
- Bank of Montreal bought 1,747 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $95.7K.
- BioMarin Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1478 holding.
- Bank of Montreal first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's BioMarin Pharmaceuticals position peaked at $32.8M in Q2 2015.
- 526 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.